Today’s teasers come in from Mark Skousen, who edits the Forecasts & Strategies newsletter and has graced our pages a few times in the past — most recently when he touted Cubist Pharmaceuticals very aggressively as a “winning lottery ticket” and “superbug killer” (that one did quite well, thanks to both the FDA and a [...]
This is a note about a teaser that you can probably solve yourself — and many of you doubtless have. And it’s also about a company I’ve written about before, about a year ago … but the questions are piling up and the enthusiasm behind this stock over the last week is a little ridiculous [...]
Dr. Stephen Leeb is jumping on the rare earths bandwagon, already crowded with newsletter pundits of every stripe, and promising that these “more precious than gold” elements will “outperform the hottest stocks.” The argument is a fairly basic one, and we’ve heard it many times: China controls most of the world’s supply of rare earth [...]